Innovations in First Line Therapy for DLBCL - 7 February 2024
Offered By: Stanford Department of Medicine via YouTube
Course Description
Overview
Explore cutting-edge advancements in first-line therapy for Diffuse Large B-Cell Lymphoma (DLBCL) in this informative Grand Rounds presentation. Led by Dr. Christopher Flowers, Head of the Division of Cancer Medicine and Chair of the Department of Lymphoma/Myeloma at The University of Texas MD Anderson Cancer Center, the 54-minute talk delves into the latest research and treatment strategies. Gain valuable insights into innovative approaches that are shaping the future of DLBCL management and improving patient outcomes. This presentation, hosted by the Stanford Department of Medicine, offers a unique opportunity to stay abreast of the evolving landscape in lymphoma treatment.
Syllabus
Innovations in First Line Therapy for DLBCL | DoM Grand Rounds | 7 February 2024
Taught by
Stanford Department of Medicine
Related Courses
Cancer in the 21st Century: The Genomic RevolutionUniversity of Glasgow via FutureLearn Inside Cancer: How Genes Influence Cancer Development
University of Bath via FutureLearn Cancer Immunotherapy: a Step Change in Cancer Treatment
University of Birmingham via FutureLearn Demystifying Targeted Cancer Treatments
Cancer Research UK via FutureLearn Discovering Science: Medicinal Chemistry
University of Leeds via FutureLearn